Why the study?
Data guiding routine cardiology clinical practice in ASCVD prevention focus on a limited number of imaging modalities, despite innovations in technology and understanding of coronary atherosclerosis pathogenesis.
This review highlights the utility of multimodality cardiovascular imaging, specifically arterial ultrasonography and computed tomography, for risk stratification and prevention of ASCVD.
Atherosclerotic cardiovascular disease (ASCVD) has been the leading cause of death worldwide for more than a decade. Prevention is of utmost importance to reduce related mortality. The innovations in cardiovascular imaging technology, in addition to our improved understanding of coronary atherosclerosis pathogenesis, have resulted in cardiovascular imaging becoming one of the most influential tools for diagnosis and risk stratification in ASCVD. Although numerous publications have emerged on this topic, data that guide routine cardiology clinical practice currently focus on the utility of a limited number of such modalities, namely arterial ultrasonography and computed tomography. Herein, current evidence with respect to the role of multimodality cardiovascular imaging on ASCVD prevention will be reviewed.
No takes yet. Share an insight, caveat, or question.
Koçyiğit et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: